Provided By GlobeNewswire
Last update: Jun 25, 2024
The pooled analysis included data from 4 international clinical trials spanning an array of hard-to-treat indications including skin, head & neck, and oral cavity.
NASDAQ:DRTSW (11/10/2025, 1:54:19 PM)
0.285
+0 (+1.79%)
NASDAQ:DRTS (11/11/2025, 11:33:12 AM)
3.85
-0.07 (-1.79%)
Find more stocks in the Stock Screener


